References
- Simren M, Barbara G, Flint HJ, et al. Intestianl microbiota in functional bowel disorders: a Rome foundation report. Gut. 2013;62:159–176.
- Simrén M. IBS with intestinal microbial dysbiosis: A new and clinically relevant subgroup? Gut. 2014;63:1685–1686.
- Dethlefsen L, Relman DA. Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc Natl Acad Sci. 2011;108:4554–4561.
- Jernberg C, Löfmark S, Edlund C, et al. Long-term impacts of antibiotic exposure on the human intestinal microbiota. Microbiology. 2010;156:3216–3223.
- Willing BP, Russell SL, Finlay BB. Shifting the balance: Antibiotic effects on host-microbiota mutualism. Nat Rev Microbiol. 2011;9:233–243.
- Mendall MA, Kumar D. Antibiotic use, childhood affluence and irritable bowel syndrome (IBS)). Eur J Gastroenterol Hepatol. 1998;10:59–62.
- Paula H, Grover M, Halder SL, et al. Non-enteric infections, antibiotic use, and risk of development of functional gastrointestinal disorders. Neurogastroenterol Motil. 2015;27:1580–1586.
- Krogsgaard LR, Engsbro AL, Jones MP, et al. The epidemiology of irritable bowel syndrome: Symptom development over a 3-year period in Denmark. A prospective, population-based cohort study. Neurogastroenterol Motil. 2017;29:e12986.
- Krogsgaard LR, Engsbro AL, Bytzer P. The epidemiology of irritable bowel syndrome in Denmark. A population-based survey in adults ≤50 years of age. Scand J Gastroenterol. 2013;48:523–529.
- Lovell RM, Ford AC. Effect of gender on prevalence of irritable bowel syndrome in the community: Systematic review and meta-analysis. Am J Gastroenterol. 2012;107:991–1000.
- Spiller R, Garsed K. Postinfectious irritable bowel syndrome. Gastroenterology. 2009;136:1979–1988.
- Klem F, Wadhwa A, Prokop LJ, et al. Prevalence, risk factors, and outcomes of irritable bowel syndrome after infectious enteritis: A systematic review and meta-analysis. Gastroenterology. 2017;152:1042–1054.
- Canavan C, West J, Card T. Review article: The economic impact of the irritable bowel syndrome. Aliment Pharmacol Ther. 2014;40:1023–1034.
- Statens Serum institut [cited 2018 Jan 24] www.medstat.dk.
- Villarreal A, Aberger FJ, Benrud R, et al. Use of broad-spectrum antibiotics and the development of irritable bowel syndrome. Wmj. 2012;111:17–20.